Product Information

CYCLOSPORINE 0.05% EYE EMULSION is a generic product labeled by KVK-Tech Inc., priced at $1.2396 per EA under NDC 10702080803. Its NADAC has been published 210 times since Aug 17, 2022.

FDA first approved this application on Dec 23, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE 0.05% EYE EMULSION

Cyclosporine
$1.2396per EA

Strength

.5 mg/mL

Manufacturer

KVK-Tech Inc.

NDC

10702080803

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA050790

FDA Approved

12/23/2002

TE Code

AB

On Market Since

2/10/2022

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE 0.05% EYE EMULSION has been published 210 times since Aug 17, 2022, and over the history we have for it it has declined 78.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2396 per EA
All-time high$5.9024 (Nov 16, 2022)
All-time low$1.2189 (Jul 22, 2026)
52-week high$2.0995
52-week low$1.2189
Median price$2.5696
Average price$2.8078
Largest weekly change-24.6% (Apr 17, 2024)
Weeks tracked210
Tracking sinceAug 17, 2022

Price History

1W

+1.7%

1M

+1.7%

3M

-18.4%

6M

-35.7%

1Y

-40.5%

3Y

-61.9%

5Y

N/A

All

-78.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE 0.05% EYE EMULSION?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 0.05% EYE EMULSION, manufactured by KVK-Tech Inc., is $1.2396 per EA (NDC 10702080803), effective Aug 19, 2026.

How has the price of CYCLOSPORINE 0.05% EYE EMULSION changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has declined 78.8%. It has been tracked across 210 weekly CMS publications since Aug 17, 2022.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 0.05% EYE EMULSION?

Since Aug 17, 2022, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has ranged from a low of $1.2189 (Jul 22, 2026) to a high of $5.9024 (Nov 16, 2022), with a median of $2.5696 per EA.

Are there cheaper alternatives to CYCLOSPORINE 0.05% EYE EMULSION?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE 0.05% EYE EMULSION, is $0.9240 per EA — about 25% below CYCLOSPORINE 0.05% EYE EMULSION.

Who manufactures CYCLOSPORINE 0.05% EYE EMULSION?

CYCLOSPORINE 0.05% EYE EMULSION (NDC 10702080803) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.